Collagenase Santyl
Payments companies reported to CMS as associated with Collagenase Santyl. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Collagenase Santyl, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Collagenase Santyl
These are the largest totals companies reported as associated with Collagenase Santyl. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| John Lantis | New York, NY | Vascular Surgery | $97,639.88 |
| Rajiv Sood | Augusta, GA | Plastic and Reconstructive Surgery | $73,713.35 |
| Michael Desvigne | Glendale, AZ | Plastic and Reconstructive Surgery | $71,083.43 |
| Hana Lopez Quinones | Bronx, NY | Surgery | $67,097.37 |
| Rodney Lindsay | Carrollton, TX | Family Medicine | $61,305.69 |
| David Zabel | Augusta, GA | Plastic Surgery | $43,285.28 |
| Amy Bruggemann | Belleville, IL | Family | $37,334.03 |
| Lourdes Castanon | Monroeville, PA | Surgical Critical Care | $22,655.20 |
| Jeffrey Lehrman | Fort Collins, CO | Foot & Ankle Surgery | $21,559.28 |
| Beretta Craft-Coffman | Canton, GA | Surgical | $20,076.30 |
Prescribed Collagenase Santyl?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.